RUA Life Sciences
Stock Forecast, Prediction & Price Target
RUA Life Sciences Financial Estimates
RUA Life Sciences Revenue Estimates
RUA Life Sciences EBITDA Estimates
RUA Life Sciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | |||
Revenue
% change YoY
| £1.52M N/A | £1.62M 6.34% | £2.19M 34.83% | Avg: £4.27M Low: £4.27M High: £4.27M avg. 95.07% | |||
Net Income
% change YoY
| £-1.45M N/A | £-2.06M -42.45% | £-1.44M 30.33% | Avg: £435K Low: £155.29K High: £155.29K avg. 130.20% | |||
EBITDA
% change YoY
| £-1.27M N/A | £-2.11M -65.44% | £-1.57M 25.66% | Avg: £-4.21M Low: £-4.21M High: £-4.21M avg. -167.90% | |||
EPS
% change YoY
| -$0.08 N/A | -$0.09 -13.65% | -$0.04 53.96% | Avg: $0.01 Low: $0.01 High: $0.01 avg. 116.31% | |||
Operating Expenses
% change YoY
| £2.77M N/A | £3.47M 25.14% | £3.65M 5.15% | Avg: £8.74M Low: £8.74M High: £8.74M avg. 139.45% | |||
FAQ
What is RUA Life Sciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 130.20% in 2026-2026.
We have gathered data from 1 analysts. Their low estimate is 155.29K, average is 435K and high is 155.29K.
What is RUA Life Sciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 95.07% in 2026-2026.
We have gathered data from 1 analysts. Their low revenue estimate is £4.27M, average is £4.27M and high is £4.27M.
What is RUA Life Sciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 116.31% in 2026-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is $0.01, average is $0.01 and high is £0.00.